The safety and tolerability of ferric citrate as a phosphate binder in dialysis patients.

@article{Sinsakul2012TheSA,
  title={The safety and tolerability of ferric citrate as a phosphate binder in dialysis patients.},
  author={Marvin V Sinsakul and Mohammed Sika and Mark J. Koury and Warren Shapiro and Tom Greene and Jamie P. Dwyer and M. E. Gonzalez Smith and Stephen M. Korbet and Julia B. Lewis},
  journal={Nephron. Clinical practice},
  year={2012},
  volume={121 1-2},
  pages={c25-9}
}
BACKGROUND A phase II open-label study was conducted in hemodialysis patients evaluating the short-term safety, tolerability, and iron absorption with ferric citrate when used as a phosphate binder. METHODS Enrollment occurred in two periods. Period 1 recruited patients taking 6-15 pills/day of binder with phosphorus of ≥2.5 mg/dl. Period 2 recruited… CONTINUE READING